Citadel Advisors LLC 13D and 13G filings for Talaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Talaris Therapeutics, Inc. TALS | Citadel Advisors LLC | 352,217 8.400% | -28,947 (-7.59%) | Filing |
| 2022-02-14 06:30 am Sale | 2021-12-31 | 13G | Talaris Therapeutics, Inc. TALS | Citadel Advisors LLC | 381,164 9.000% | -222 (-0.06%) | Filing |
| 2021-05-21 4:08 pm Purchase | 2021-05-11 | 13G | Talaris Therapeutics, Inc. TALS | Citadel Advisors LLC | 381,386 9.200% | 381,386 (New Position) | Filing |